RNA Q4 2023 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-20.8% YoY

Gross Profit

$2M72.0% margin

Operating Income

-$67M-3043.5% margin

Net Income

-$60M-2756.2% margin

EPS (Diluted)

$-0.79

QoQ Revenue Growth

-22.2%

Cash Flow

Operating Cash Flow

$17M

Free Cash Flow

$16M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$629M

Total Liabilities

$128M

Stockholders' Equity

$501M

Cash & Equivalents

$185M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$3M	-20.8%
Gross Profit	$2M	-$43M	+103.7%
Operating Income	-$67M	-$53M	-25.4%
Net Income	-$60M	-$50M	-19.8%